SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trillium Therapeutics
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
294 39 0 TRIL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
269No rush on my side. Too many mistakes.Miljenko Zuanic-2/28/2019
26820+ abstracts at AACR when cd47 used in search. Interesting one from Arch Onco semi_infinite -2/28/2019
267Well, one take-home from the publication that Tuck just pointed to is that CD47 scaram(o)uche-2/22/2019
266Wasn't aware that it is. Haven't submitted a contest entry with any effscaram(o)uche12/22/2019
265622 is IgG4Fc....is there chance that this may work in combo...60c/share is not Miljenko Zuanic-2/22/2019
264Rick, Why is TRIL in your Contest portfolio? You seem to had this right all alBladerunner17-2/22/2019
263>> what do you think of scaramouche's criticisms of TRIL? << Clscaram(o)uche-2/22/2019
262One quarter of operating expenses is a band aid unless some spectacular data comsemi_infinite -2/22/2019
261And one warrant per unit at 96 cents. Jeez. Cheers, Tucktuck-2/22/2019
260Say, it's been a while since I've been asked by the IR team to update thtuck12/22/2019
259Today's stories, two biotechs (immunotherapy of cancer) that ran out of monescaram(o)uche-2/21/2019
258The modestly increased volume and capped price caught my eye today. The ask wasscaram(o)uche-2/21/2019
257The first two authors contributed equally to the work. Second author is from Irscaram(o)uche-2/21/2019
256A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPtuck-2/21/2019
255Am seeing an offering of $15 million @ 80 cents/share. Wondering if I dare taketuck-2/21/2019
254CD16A subset (158F, 85% of patients) is a thing of beauty. Read-through to AFMDscaram(o)uche-2/6/2019
253A bit surprised that not a single one chose MGNX to be part of charity contest. semi_infinite -2/6/2019
252Or opposite?Miljenko Zuanic-2/5/2019
251Price and volume suggest a raise is imminent. BladerunnerBladerunner17-2/5/2019
250Cool paper! Thanks. And what do we get from R&D at Trillium? Isotype swapscaram(o)uche-2/2/2019
249tril/afmd/mgnx - A review of bispecific ABS development and clinical trials. ncsemi_infinite -2/2/2019
248Some stats on CR in Sezary. 8.3% in this review. ncbi.nlm.nih.govsemi_infinite -1/26/2019
247I saw this article this morning in endpts. turning the table on cd47 Not sure atticus4paws-1/23/2019
246anti CD47 potential issue with susceptibility to infections in NIH murine modelssemi_infinite -1/22/2019
245Whoops! Went through it too fast the first time. Saw the new stuff (or new tatticus4paws-1/16/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News